United States · FDA National Drug Code directory
GUAIFENESIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 30142-961_5b667b46-235a-4d9c-aea1-0ec8286e3bbc
- Product NDC
- 30142-961
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Guaifenesin
- Labeler
- Kroger Company
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220428
- Source listing expiry
- 20261231
Source-listed ingredients
- GUAIFENESIN — 600 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (30142-961-20) / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 30142-961-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →